Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

| More on:
The Motley Fool

On March 21, there were more developments in the Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) saga.

Most notably, the company announced that CEO Michael Pearson will be stepping down as soon as a successor is found. In addition, activist investor Bill Ackman, head of Pershing Square Capital Management, has now joined the board of directors. And to top it all off, Valeant blamed its past financial misstatements on former CFO Howard Schiller and asked him to resign from the board of directors. Yet he has refused to do so.

While these developments may look like signs of chaos, investors reacted warmly to the news, sending Valeant’s shares up by as much as 17%. So why exactly did Valeant’s shares increase, and what does this news mean for the company in the long term?

Michael Pearson’s departure

Michael Pearson has been the face of Valeant’s rise as well as its fall. It was he who moved the company from the United States to Canada primarily for tax reasons. It was he who slashed Valeant’s R&D spending in favour of an acquisition-based model. And as the company finds itself in a downward spiral, he is at the centre of it all.

Up until March he was still held in very high regard. When the Philidor story dominated headlines, Mr. Ackman reiterated his support for Mr. Pearson. Then when Mr. Pearson had to step down at the end of 2015 (for health-related reasons), Valeant’s share price fell. More recently, Nomura Securities analyst Shibani Malhotra said Valeant would lose its competitive advantage if Mr. Pearson stepped down.

But that all changed when Valeant lowered its 2016 guidance on March 14. Now there’s a sense that the company has no idea what it’s doing, which, of course, reflects badly on the CEO. So it’s no surprise that his departure is being received well.

Bill Ackman’s presence

Not unlike Mr. Pearson, Bill Ackman is another public figure whose reputation has taken a dramatic turn for the worse.

Long known as one of Wall Street’s best activist investors, Mr. Ackman has had some remarkable successes; for example, he initiated the turnaround at Canadian Pacific Railway Limited, which has been a tremendous win for shareholders of that company.

But more recently, the story has been very different. When Valeant started running into trouble, he increased his stake, saying his biggest regret was that he wasn’t in a position to buy more shares. He also said that the company’s biggest problem was poor communication. During a conference call, he even predicted that Valeant’s shares would reach US$448 by 2019.

Yet Mr. Ackman still is held in high regard, so his decision to join the board may be viewed as a small positive.

Howard Schiller

It may seem unfair that Mr. Schiller is being made the scapegoat, since he stepped in as interim-CEO during a very difficult time. Then again, he was CFO at a time when the company misstated its financials.

In any case, this controversy is really more of a side story. Mr. Pearson’s departure was certainly the main reason Valeant’s share price increased, and Mr. Ackman’s increased involvement was likely a factor as well. We’ll have to wait and see how this all plays out.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

senior relaxes in hammock with e-book
Dividend Stocks

Top Picks: 3 Canadian Dividend Stocks for Stress-Free Passive Income

For investors looking to pick up reasonable dividend income, but also want to sleep well at night, here are three…

Read more »

Real estate investment concept with person pointing on growth graph and coin stacking to get profit from property
Dividend Stocks

A 7.4% Dividend Yield to Hold for Decades? Yes Please!

Think all high yields are risky? MCAN Financial’s regulated, interest-first model could be a dividend built to last.

Read more »

Stacked gold bars
Metals and Mining Stocks

Locking in Gains by Selling Gold Stocks? Here’s Where to Invest Next

After gold's 137% surge in 2025, shift profits to copper, uranium, and oil dividend plays for AI and energy growth…

Read more »

man looks worried about something on his phone
Energy Stocks

1 No-Brainer Energy Stock to Buy With $500 Right Now

Learn why energy stock investments are essential in Canada, focusing on Canadian Natural Resources as a top choice for investors.

Read more »

dividend growth for passive income
Dividend Stocks

3 Canadian Dividend Stocks to Buy and Hold for 20 Years

Three TSX dividend stocks built to keep paying through recessions, rate hikes, and market drama so you can set it…

Read more »

diversification is an important part of building a stable portfolio
Dividend Stocks

TFSA Passive Income: 2 TSX Dividend Stocks to Consider Now

Building out a passive income portfolio with great TSX dividend stocks is easier than it sounds. Here are 2 stocks…

Read more »

top TSX stocks to buy
Dividend Stocks

How to Build a TFSA That Earns +$200 of Safe Monthly Income

If you want to earn monthly income, here is a four-stock portfolio that could collectively earn over $200 per monthly…

Read more »

ETF stands for Exchange Traded Fund
Stocks for Beginners

Here Are My 2 Favourite ETFs for 2026 

Explore how ETFs can enhance your investment portfolio strategy with balanced returns and market diversification.

Read more »